ferric chloride has been researched along with Hemorrhage in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 1 (4.76) | 29.6817 |
2010's | 18 (85.71) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Alfar, HR; Aronova, M; Joshi, S; Leapman, RD; Lykins, J; Pokrovskaya, I; Prakhya, KS; Smith, AN; Storrie, B; Whiteheart, SW; Zhang, M | 1 |
Abdelfadiel, EI; Afosah, DK; Al-Horani, RA; Brophy, DF; Desai, UR; Martin, EJ; Mohammed, B; Morla, S; Sakagami, M; Sistla, JC | 1 |
Chang, CH; Chung, CH; Hsu, CC; Huang, TF; Peng, HC; Tsai, CC; Tseng, YJ; Tu, YS | 1 |
Adler, K; Borst, O; Brandl, R; Degen, H; Fassbender, J; Gawaz, M; Göbel, S; Jamasbi, J; Lorenz, R; Mojica Munoz, AK; Münch, G; Siess, W; Ungerer, M; Walker, B; Ziegler, M | 1 |
Dai, X; Hou, Y; Lei, X; Li, BX; Liang, C; Marshall, AH; Ni, H; Reheman, A; Vanhoorelbeke, K; Wang, Y; Zhou, H | 1 |
Heo, JH; Hong, SY; Kang, S; Kim, YD; Kwon, I; Nam, HS; Yang, SH | 1 |
Baskaran, P; Berk, BC; Kim, Y; Modjeski, K; Morrell, CN; Smolock, EM; Soe, NN; Sowden, M; Wang, L; Xu, Y | 1 |
Cheng, Q; Gailani, D; Ivanov, IS | 1 |
Andre, P; Bentley, R; Cai, TQ; Chen, Z; Desai, K; DiPietro, M; Hoos, L; Jochnowitz, N; Lai, K; Leander, K; Levorse, J; Metzger, JM; Seiffert, D; Sepp-Lorenzino, L; Shin, MK; Strapps, WR; Tadin-Strapps, M; Thankappan, A; Wu, W; Xu, Y; Zhang, Z; Zhou, Y | 1 |
Bentley, R; Cai, TQ; Chen, Z; Hoos, L; Jochnowitz, N; Metzger, JM; Ogletree, ML; Seiffert, DA; Shin, MK; Strapps, W; Tadin-Strapps, M; Thankappan, A; Wu, W; Xu, Y; Zhou, Y | 1 |
Cao, Y; Gu, J; Huang, W; Ji, C; Lee, KH; Li, K; Ma, L; Morris-Natschke, SL; Niu, H; Qin, C; Wei, Z; Wen, L; Xia, Q; Xin, G; Xing, Z; Yeh, JL; Zhang, R; Zheng, H | 1 |
Elg, M; Johansson, K; Kjaer, M; Pehrsson, S | 1 |
Alonso-Martín, S; Ayuso, MS; Fernández, D; González-Manchón, C; Larrucea, S; Parrilla, R; Pericacho, M; Sánchez, I | 1 |
Bhakta, V; Eltringham-Smith, LJ; Gataiance, S; Sheffield, WP | 1 |
Barbera, F; Bird, JE; Revelli, JP; Schumacher, WA; Seiffert, D; Smith, PL; Wang, X | 1 |
Boulaftali, Y; Bouton, MC; Ho-Tin-Noé, B; Jandrot-Perrus, M; Lamrani, L; Loyau, S; Rouzaud, MC | 1 |
Crescente, M; Demers, M; Ho-Tin-Noé, B; Thomas, GM; Voorhees, JR; Wagner, DD; Wong, SL | 1 |
Ding, Z; Du, H; Liu, G; Pan, C; Wei, X; Ye, J; Zhang, S; Zhang, Y | 1 |
Casari, C; Christophe, OD; Denis, CV; Hu, JR; Legendre, P; Lenting, PJ; Marx, I; Navarrete, AM | 1 |
Ablooglu, AJ; Fogelstrand, P; Ginsberg, MH; Partridge, AW; Petrich, BG; Shattil, SJ; Yousefi, N | 1 |
Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y | 1 |
21 other study(ies) available for ferric chloride and Hemorrhage
Article | Year |
---|---|
Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis.
Topics: Blood Platelets; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Humans; Microscopy, Electron; Thrombosis | 2023 |
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.
Topics: Allosteric Regulation; Animals; Anticoagulants; Blood Coagulation; Chlorides; Disease Models, Animal; Factor XIa; Female; Ferric Compounds; Hemorrhage; Heparin; Humans; Inositol; Molecular Mimicry; Rats, Wistar; Risk Assessment; Sulfates; Thrombosis | 2019 |
Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Topics: Animals; Binding Sites; Blood Platelets; Carotid Artery Injuries; Chlorides; Computer-Aided Design; Crotalid Venoms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Ferric Compounds; Fibrinolytic Agents; Fluorescein; Hemorrhage; Humans; Lectins, C-Type; Male; Mice, Inbred ICR; Molecular Docking Simulation; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Protein Interaction Domains and Motifs; Signal Transduction; Thrombosis | 2017 |
ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Topics: Animals; Antigens, CD; Apyrase; Carotid Artery Diseases; Carotid Artery Injuries; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ferric Compounds; Fibrinolytic Agents; Glycoproteins; Hemorrhage; Humans; Immunoglobulin Fc Fragments; Male; Mice, Inbred C57BL; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Recombinant Fusion Proteins; Thrombosis | 2017 |
Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Topics: Animals; Binding Sites; Blood Platelets; Chlorides; Crotalid Venoms; Disease Models, Animal; Female; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Lectins, C-Type; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Thrombosis; Time Factors; Vascular System Injuries; von Willebrand Factor | 2014 |
Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice.
Topics: Animals; Blood Platelets; Carotid Arteries; Cells, Cultured; Chlorides; Disintegrins; Dose-Response Relationship, Drug; Drug Administration Schedule; Ferric Compounds; Fibrinolytic Agents; Hemorheology; Hemorrhage; Integrins; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Snake Venoms; Thrombolytic Therapy; Thrombosis | 2013 |
Cyclophilin A is an important mediator of platelet function by regulating integrin αIIbβ3 bidirectional signalling.
Topics: Animals; Blood Platelets; Cell Adhesion; Cells, Cultured; Chlorides; Cyclophilin A; Cytoskeleton; Ferric Compounds; Fibrinogen; Hemorrhage; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Reactive Oxygen Species; Signal Transduction; Thrombin; Thrombosis | 2014 |
Murine models in the evaluation of heparan sulfate-based anticoagulants.
Topics: Animals; Anticoagulants; Chlorides; Disease Models, Animal; Ferric Compounds; Hemorrhage; Heparitin Sulfate; Mice, Inbred C57BL; Tail; Thrombosis; Vena Cava, Inferior | 2015 |
Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability.
Topics: Animals; Cell Line; Chlorides; Disease Models, Animal; Factor IX; Ferric Compounds; Gene Expression Regulation; Genotype; Hemophilia B; Hemorrhage; Hemostasis; Liver; Male; Phenotype; Rats; Rats, Sprague-Dawley; Rats, Transgenic; RNA Interference; RNA, Messenger; RNA, Small Interfering; RNAi Therapeutics; Thrombosis; Time Factors; Transfection | 2015 |
Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding.
Topics: Animals; Arteriovenous Shunt, Surgical; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Ellagic Acid; Endodeoxyribonucleases; Factor XII; Ferric Compounds; Gene Knockout Techniques; Hemorrhage; Humans; Liver; Male; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Thrombin; Thrombolytic Therapy; Thrombosis; Zinc Fingers | 2015 |
Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release.
Topics: Animals; Antioxidants; Beer; Carotid Arteries; Cell Adhesion Molecules; Chlorides; Dendritic Cells; DNA, Mitochondrial; Ferric Compounds; Fibrinolytic Agents; Flavonoids; Hemorrhage; Humans; Humulus; Lectins, C-Type; Mice; Mice, Inbred C57BL; Platelet Activation; Platelet Aggregation Inhibitors; Propiophenones; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Cell Surface; Risk; Sirtuin 1; Thrombosis | 2017 |
Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Topics: Amidines; Animals; Antithrombin III; Antithrombins; Azetidines; Blood Coagulation; Chlorides; Dalteparin; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Infusions, Intravenous; Male; Partial Thromboplastin Time; Peptide Hydrolases; Prodrugs; Rats; Rats, Sprague-Dawley; Thrombin; Thrombin Time; Thrombosis; Venous Thrombosis | 2010 |
Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes.
Topics: Animals; Blood Coagulation; Blood Platelets; Carotid Arteries; Cell Count; Chlorides; Ferric Compounds; Gene Deletion; Hemorrhage; Megakaryocytes; Mice; Mice, Inbred C57BL; Platelet Adhesiveness; Platelet Aggregation; Sialoglycoproteins; Thrombosis | 2011 |
Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Topics: alpha 1-Antitrypsin; Animals; Antithrombins; Carotid Artery Injuries; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Endotoxins; Factor Xa; Factor Xa Inhibitors; Factor XIa; Factor XIIa; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Injections, Intravenous; Kinetics; Leukocyte Elastase; Mice; Mutation; NG-Nitroarginine Methyl Ester; Recombinant Fusion Proteins; Thrombin; Thrombosis | 2012 |
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait.
Topics: Animals; Bleeding Time; Chlorides; Disease Models, Animal; Ferric Compounds; Hemorrhage; Hemostasis; Heterozygote; Mice; Mice, Knockout; Oligonucleotides, Antisense; Partial Thromboplastin Time; Phenotype; Plasma Kallikrein; Prekallikrein; Thrombosis; Time Factors; Venous Thrombosis | 2012 |
The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
Topics: Animals; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ferric Compounds; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Plasminogen Activator Inhibitor 1; Recombinant Proteins; Skin; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator | 2012 |
ADAMTS13 exerts a thrombolytic effect in microcirculation.
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Chlorides; Computer Systems; Disease Models, Animal; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Humans; Male; Mice; Mice, Inbred C57BL; Microcirculation; Microscopy; Recombinant Proteins; Skin Window Technique; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis; Venules | 2012 |
BF066, a novel dual target antiplatelet agent without significant bleeding.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenine; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Arterioles; Chlorides; Collagen; Ferric Compounds; Fibrinogen; Hemorrhage; Humans; Immobilized Proteins; Mice; Mice, Inbred C57BL; Oligopeptides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Adenosine A2A; Thrombin; Thrombosis | 2012 |
A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor.
Topics: ADAMTS13 Protein; Animals; Antibodies, Monoclonal; Chlorides; Collagen; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Humans; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Mutation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; von Willebrand Factor | 2012 |
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.
Topics: Amino Acid Substitution; Anemia; Animals; Blood Platelets; Chlorides; Contractile Proteins; Ferric Compounds; Fibrinogen; Filamins; Hemorrhage; Homozygote; Mice; Mice, Transgenic; Microfilament Proteins; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Protein Binding; Protein Structure, Tertiary; Pulmonary Embolism; Talin; Thrombosis | 2007 |
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Chlorides; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Glass; Hemorrhage; Heparin; Hirudin Therapy; Hirudins; Molecular Sequence Data; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombosis; Vena Cava, Inferior; Venous Thrombosis | 1999 |